Eliem Therapeutics, Inc. (ELYM)
NASDAQ: ELYM · IEX Real-Time Price · USD
7.30
+0.53 (7.83%)
At close: Jul 19, 2024, 4:00 PM
8.13
+0.83 (11.37%)
Pre-market: Jul 22, 2024, 7:51 AM EDT
Eliem Therapeutics Market Cap
Eliem Therapeutics has a market cap or net worth of $487.53 million as of July 22, 2024. Its market cap has increased by 501.89% in one year.
Market Cap
487.53M
Enterprise Value
382.73M
1-Year Change
501.89%
Ranking
Category
Stock Price
$7.30
Market Cap Chart
Since the IPO on August 10, 2021, Eliem Therapeutics's market cap has increased from $316.98M to $487.53M, an increase of 53.81%. That is a compound annual growth rate of 15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 212.40M | 185.48% |
| Dec 29, 2023 | 74.40M | -23.69% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.80M | -12.36% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 497.23M |
| Jin Medical International | 490.78M |
| Heron Therapeutics | 489.62M |
| Oculis Holding AG | 488.72M |
| Treace Medical Concepts | 488.62M |
| Fate Therapeutics | 486.06M |
| biote | 485.75M |
| Third Harmonic Bio | 483.61M |